Abstract
AIM—To describe the epidemiology, management, and rate of cardiac sequelae of Kawasaki disease in Australia. DESIGN—Cases were notified to the Australian Paediatric Surveillance Unit, an active national surveillance scheme, from May 1993to June 1995. RESULTS—139 cases of Kawasaki disease were confirmed. In 1994, the annual incidence was 3.7/100 000 children < 5 years old. Sixteen children were not admitted to hospital. Coronary artery abnormalities were reported in 35 (25%) children. Two patients were diagnosed at postmortem examination. Sixty six per cent of patients were diagnosed within 10 days of onset and 81% of these received intravenous gammaglobulin within 10 days. Forty five of the notified children did not fulfil the study criteria because of streptococcal infection or insufficient clinical criteria. One child with streptococcal infection had coronary artery dilatation. CONCLUSION—Diagnosis of Kawasaki disease was delayed beyond 10 days in one third of patients, and almost 20% of children who could have received gammaglobulin within 10 days did not. The distinction between Kawasaki disease, streptococcal infection, and other possible diagnoses is problematic in some children.
Full Text
The Full Text of this article is available as a PDF (109.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Akiyama T., Yashiro K. Probable role of Streptococcus pyogenes in Kawasaki disease. Eur J Pediatr. 1993 Feb;152(2):82–92. doi: 10.1007/BF02072479. [DOI] [PubMed] [Google Scholar]
- Anderson D. G., Warner G., Barlow E. Kawasaki disease associated with streptococcal infection within a family. J Paediatr Child Health. 1995 Aug;31(4):355–357. doi: 10.1111/j.1440-1754.1995.tb00827.x. [DOI] [PubMed] [Google Scholar]
- Burns J. C., Mason W. H., Glode M. P., Shulman S. T., Melish M. E., Meissner C., Bastian J., Beiser A. S., Meyerson H. M., Newburger J. W. Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. J Pediatr. 1991 May;118(5):680–686. doi: 10.1016/s0022-3476(05)80026-5. [DOI] [PubMed] [Google Scholar]
- Choi Y. S., Sharma B. Gallbladder hydrops in mucocutaneous lymph node syndrome. South Med J. 1989 Mar;82(3):397–398. doi: 10.1097/00007611-198903000-00032. [DOI] [PubMed] [Google Scholar]
- Curtis N., Zheng R., Lamb J. R., Levin M. Evidence for a superantigen mediated process in Kawasaki disease. Arch Dis Child. 1995 Apr;72(4):308–311. doi: 10.1136/adc.72.4.308. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dajani A. S., Taubert K. A., Gerber M. A., Shulman S. T., Ferrieri P., Freed M., Takahashi M., Bierman F. Z., Karchmer A. W., Wilson W. Diagnosis and therapy of Kawasaki disease in children. Circulation. 1993 May;87(5):1776–1780. doi: 10.1161/01.cir.87.5.1776. [DOI] [PubMed] [Google Scholar]
- Dhillon R., Newton L., Rudd P. T., Hall S. M. Management of Kawasaki disease in the British Isles. Arch Dis Child. 1993 Dec;69(6):631–638. doi: 10.1136/adc.69.6.631. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Elliott E. J., Chant K. G. Rare disease surveillance. J Paediatr Child Health. 1994 Dec;30(6):463–465. doi: 10.1111/j.1440-1754.1994.tb00711.x. [DOI] [PubMed] [Google Scholar]
- Furusho K., Kamiya T., Nakano H., Kiyosawa N., Shinomiya K., Hayashidera T., Tamura T., Hirose O., Manabe Y., Yokoyama T. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet. 1984 Nov 10;2(8411):1055–1058. doi: 10.1016/s0140-6736(84)91504-6. [DOI] [PubMed] [Google Scholar]
- Gentles T. L., Clarkson P. M., Trenholme A. A., Lennon D. R., Neutze J. M. Kawasaki disease in Auckland, 1979-1988. N Z Med J. 1990 Aug 22;103(896):389–391. [PubMed] [Google Scholar]
- Hoare S., Abinun M., Cant A. J. Overlap between Kawasaki disease and group A streptococcal infection. Pediatr Infect Dis J. 1997 Jun;16(6):633–634. doi: 10.1097/00006454-199706000-00022. [DOI] [PubMed] [Google Scholar]
- Kawasaki N., Morimoto K., Hayakawa T. [Study on evaluating methods for the quality control of glycoprotein products. (1). Erythropoietin products]. Eisei Shikenjo Hokoku. 1995;(113):69–73. [PubMed] [Google Scholar]
- Kawasaki T. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi. 1967 Mar;16(3):178–222. [PubMed] [Google Scholar]
- Leung D. Y., Giorno R. C., Kazemi L. V., Flynn P. A., Busse J. B. Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome. J Immunol. 1995 Nov 15;155(10):5018–5021. [PubMed] [Google Scholar]
- Leung D. Y., Meissner H. C., Fulton D. R., Murray D. L., Kotzin B. L., Schlievert P. M. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet. 1993 Dec 4;342(8884):1385–1388. doi: 10.1016/0140-6736(93)92752-f. [DOI] [PubMed] [Google Scholar]
- Melish M. E., Hicks R. M., Larson E. J. Mucocutaneous lymph node syndrome in the United States. Am J Dis Child. 1976 Jun;130(6):599–607. doi: 10.1001/archpedi.1976.02120070025006. [DOI] [PubMed] [Google Scholar]
- Morens D. M., Anderson L. J., Hurwitz E. S. National surveillance of Kawasaki disease. Pediatrics. 1980 Jan;65(1):21–25. [PubMed] [Google Scholar]
- Nagashima M., Matsushima M., Matsuoka H., Ogawa A., Okumura N. High-dose gammaglobulin therapy for Kawasaki disease. J Pediatr. 1987 May;110(5):710–712. doi: 10.1016/s0022-3476(87)80007-0. [DOI] [PubMed] [Google Scholar]
- Newburger J. W., Takahashi M., Beiser A. S., Burns J. C., Bastian J., Chung K. J., Colan S. D., Duffy C. E., Fulton D. R., Glode M. P. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991 Jun 6;324(23):1633–1639. doi: 10.1056/NEJM199106063242305. [DOI] [PubMed] [Google Scholar]
- Newburger J. W., Takahashi M., Burns J. C., Beiser A. S., Chung K. J., Duffy C. E., Glode M. P., Mason W. H., Reddy V., Sanders S. P. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986 Aug 7;315(6):341–347. doi: 10.1056/NEJM198608073150601. [DOI] [PubMed] [Google Scholar]
- Reller M., DeCristofaro J., Schwartz D. C. Coronary aneurysms in a patient with atypical Kawasaki syndrome and a streptococcal infection. Pediatr Cardiol. 1984 Jul-Sep;5(3):205–207. doi: 10.1007/BF02427046. [DOI] [PubMed] [Google Scholar]
- Rowley A. H., Gonzalez-Crussi F., Shulman S. T. Kawasaki syndrome. Rev Infect Dis. 1988 Jan-Feb;10(1):1–15. doi: 10.1093/clinids/10.1.1. [DOI] [PubMed] [Google Scholar]
- Rowley A. H., Shulman S. T. Current therapy for acute Kawasaki syndrome. J Pediatr. 1991 Jun;118(6):987–991. doi: 10.1016/s0022-3476(05)82225-5. [DOI] [PubMed] [Google Scholar]
- Rowley A. H., Shulman S. T. What is the status of intravenous gamma-globulin for Kawasaki syndrome in the United States and Canada? Pediatr Infect Dis J. 1988 Jul;7(7):463–466. doi: 10.1097/00006454-198807000-00001. [DOI] [PubMed] [Google Scholar]
- Smith P. K., Goldwater P. N. Kawasaki disease in Adelaide: a review. J Paediatr Child Health. 1993 Apr;29(2):126–131. doi: 10.1111/j.1440-1754.1993.tb00464.x. [DOI] [PubMed] [Google Scholar]
- Taubert K. A., Rowley A. H., Shulman S. T. Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J. 1994 Aug;13(8):704–708. doi: 10.1097/00006454-199408000-00005. [DOI] [PubMed] [Google Scholar]
- Yanagawa H., Kawasaki T., Shigematsu I. Nationwide survey on Kawasaki disease in Japan. Pediatrics. 1987 Jul;80(1):58–62. [PubMed] [Google Scholar]
- Yanagawa H., Yashiro M., Nakamura Y., Kawasaki T., Kato H. Epidemiologic pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992. Pediatrics. 1995 Apr;95(4):475–479. [PubMed] [Google Scholar]